This country profile provides an overview of the Democratic Republic of the Congo’s progress in reaching those in need of mass NTD treatment based on 2019 data.

*This includes all countries in Africa that are endemic for at least one of the five NTDs

Treatment coverage

Elephantiasis
80%
Blinding trachoma
57%
Intestinal worms
86%
Bilharzia
68%
River blindness
81%
52.26 million people received treatment in the Democratic Republic of the Congo in 2019 1.06 million people did not receive treatment in the Democratic Republic of the Congo in 2019

Elephantiasis

Treatment coverage increased from 77% in 2018 to 80% in 2019.

People needing treatment
46.05m
People receiving treatment
36.95m

Blinding trachoma

Treatment coverage increased from 19% in 2018 to 57% in 2019.

People needing treatment
12.53m
People receiving treatment
7.14m

Intestinal worms

Treatment coverage increased from 52% in 2018 to 86% in 2019.

Pre-sch and school-aged children needing treatment
29.64m
Pre-school and school-aged children receiving treatment
25.58m

Bilharzia

Treatment coverage decreased from 69% in 2018 to 68% in 2019.

School-aged children needing treatment
11.19m
School-aged children receiving treatment
7.56m

River blindness

Treatment coverage increased from 79% in 2018 to 81% in 2019.

People needing treatment
49.33m
People receiving treatment
39.81m

The ESPEN portal (a World Health Organization AFRO region project) provides maps and district-level data for the preventive chemotherapy diseases in the Democratic Republic of the Congo.